Compulsory licensing sets off a wave of price cuts in cancer drugsLivemintSome of the key cancer drugs under patent protection in India—erlotinib (lung cancer), sunitinib (kidney cancer), sorafenib (liver and kidney cancer), trastuzumab (breast cance…
Rituximab Promotes Long-Term Response for Patients with Immune Destruction of …Business Review India (press release)WASHINGTON, May 7, 2012 /PRNewswire-USNewswire/ — A new analysis concludes that rituximab, a drug commonly used to treat blood cancer…
Rituximab promotes long-term response for patients with immune destruction of …Medical XpressA new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximate…
Rituximab Promotes Long-Term Response for Patients with Immune Destruction of …MarketWatch (press release)WASHINGTON, May 7, 2012 /PRNewswire via COMTEX/ — A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads t…
Daiichi Sankyo And Coherus BioSciences Establish Strategic Collaboration To …MarketWatch (press release)Ltd. (hereafter, Daiichi Sankyo; TSE 4568) announced today the execution of an exclusive agreement to develop and commercialize biosimilar forms o…
Gilead Sciences begins phase III trial of leukaemia drugZenopaThe first patient has been dosed as part of Study 116, a trial that will assess the safety and efficacy of the drug in combination with rituximab among 160 subjects across Europe and the US….
Lupus Nephritis: First ACR Guidelines PublishedMedscapeRituximab or calcineurin inhibitors should be considered if standard treatments fail." Dr. Hahn also noted that an algorithm for management of pregnant woman with active [LN] is included in th…
New biologics and biosimilars approval guidelines in MexicoThe Pharma LetterFor example, Probiomed already sells six non-originator biologics, including Kikuzubam (rituximab), which is Probiomed's version of Roche's Rituxan/MabThera (rituximab)…
The Deal PipelineAbbott continues to prep for new focusThe Deal PipelineIt has also supplemented its pipeline through additional partnerships over the past few years, forging deals with Reata, Biogen Idec Inc. (daclizumab for multiple sclerosis) and Br…
In Mexico, New Guidelines Are Now in Effect for the Market Authorization of …EON: Enhanced Online News (press release)For example, Probiomed already sells six non-originator biologics, including Kikuzubam (rituximab), which is Probiomed's version…